Finance

News Review: EQT GP Holdings, LP (NYSE:EQGP), Ohr Pharmaceutical, Inc. (NASDAQ:OHRP)

EQT GP Holdings, LP (NYSE:EQGP)’s Financial Overview

EQT GP Holdings, LP (NYSE) reported its last quarterly earnings on 9/29/2018 where the firm reported its Actual EPS of $0.31/share against the analyst consensus estimate of $0.3/share. The difference between the actual and expected EPS is $0.01 a share with a surprise factor of 3.3%.

Our vendor, Zacks Investment Research, hasn’t provided us with the upcoming earnings report date.

Ohr Pharmaceutical, Inc. (NASDAQ:OHRP)

Ohr Pharmaceutical, Inc. is a pharmaceutical company. It is focused on the development of novel therapeutics for the treatment of cancer cachexia, wet form of age-related macular degeneration and ophthalmic neovascularization disorders. Ohr Pharmaceutical, Inc. is headquartered in New York.

Ohr Pharmaceutical, Inc. (NASDAQ:OHRP)’s Financial Outlook

The 1 analysts offering 12-month price forecasts for OHR Pharmaceutical Inc have a median target of 8.00, with a high estimate of 8.00 and a low estimate of 8.00. The median estimate represents a +226.53% increase from the last price of 2.45.

Our vendor, Zacks Investment Research, hasn’t provided us with the upcoming earnings report date.

The Stock surged 4.26% and closed its last trading session at $2.45. The company has the market capitalization of $7.84 Million. The stock has 52-week high of $6.6 and 52-Week low of $1.6. The firm touched its 52-Week high on 6.56 and 52-Week low on 1.58. The company has volume of 96212 shares. The company has a total of 3.2 Million shares outstanding.

Ohr Pharmaceutical, Inc. (NASDAQ) in the last quarter reported its actual EPS of $-0.05/share where the analyst estimated EPS was $-0.07/share. The difference between the actual and Estimated EPS is $0.02. This shows a surprise factor of 28.6 percent.

The company has YTD performance of 42.44 percent. Beta for Ohr Pharmaceutical, Inc. stands at 1.09 while its ATR (average true range) is 0.48. The company has Weekly Volatility of 27.86%% and Monthly Volatility of 17.19%%.

Ohr Pharmaceutical, Inc. has distance from 20-day Simple Moving Average (SMA20) of 8.46%, Distance from 50-Day Simple Moving Average of 2.82 percent and Distance from 200-Day Simple Moving Average of -29.42%.

The Company currently has ROA (Return on Assets) of -66.8 percent, Return on Equity (ROE) of -71.5 Percent and Return on Investment (ROI) of 0% with Gross margin of 0 percent and Operating & Profit margin of 0% and 0% respectively.